Search
Close this search box.

July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment

Mbem’s Nkala’ah festival celebrates culture and athletics

The 2024 Nkala’ah festival in Cameroon’s Nwa subdivision, North West region, was a success, showcasing cultural traditions and featuring a well-organized Mini Majang Race.

Local athletes Gabsebuin Prophet and Bonwi Sidonie triumphed in the Mini Race’…

Santchou: Trigger-happy gendarme shoots teenager to death

The people of Santchou in Dschang, West region of Cameroon, on Thursday afternoon, blocked the road linking the Menoua Division and Douala in the Littoral region, demanding the head of the gendarme who shot the child.

Local media report that the Gend…

36th Regular Session of HPR Underway in Presence of PM Abiy

Addis Ababa: Ethiopia’s House of Peoples Representatives (HPR) is holding its 36th regular session in the presence of Prime Minister Abiy Ahmed.

The Prime Minister will address questions from members of the House in addition to his explanation about …